BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24390137)

  • 1. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.
    Villarroel VA; Okiyama N; Tsuji G; Linton JT; Katz SI
    J Invest Dermatol; 2014 Jun; 134(6):1552-1560. PubMed ID: 24390137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice.
    Shibaki A; Sato A; Vogel JC; Miyagawa F; Katz SI
    J Invest Dermatol; 2004 Jul; 123(1):109-15. PubMed ID: 15191550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease.
    Miyagawa F; Tagaya Y; Kim BS; Patel HJ; Ishida K; Ohteki T; Waldmann TA; Katz SI
    J Immunol; 2008 Jul; 181(2):1109-19. PubMed ID: 18606663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
    Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
    J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16E7-Induced Hyperplasia Promotes CXCL9/10 Expression and Induces CXCR3
    Kuo P; Tuong ZK; Teoh SM; Frazer IH; Mattarollo SR; Leggatt GR
    J Invest Dermatol; 2018 Jun; 138(6):1348-1359. PubMed ID: 29277541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.
    Okiyama N; Katz SI
    J Autoimmun; 2014 Sep; 53():1-9. PubMed ID: 25047812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
    Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD3+CD4-CD8- T cells as potential regulatory cells in an experimental murine model of graft-versus-host skin disease (GVHD).
    Miyagawa F; Okiyama N; Villarroel V; Katz SI
    J Invest Dermatol; 2013 Nov; 133(11):2538-2545. PubMed ID: 23648548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of mouse models to better understand mechanisms of autoimmunity and tolerance.
    Miyagawa F; Gutermuth J; Zhang H; Katz SI
    J Autoimmun; 2010 Nov; 35(3):192-8. PubMed ID: 20655706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells inhibit CD8(+) T-cell tissue invasion in human skin graft-versus-host reactions.
    Mavin E; Ahmed SS; O'Boyle G; Turner B; Douglass S; Norden J; Collin M; Ali S; Dickinson A; Wang XN
    Transplantation; 2012 Sep; 94(5):456-64. PubMed ID: 22890131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
    Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
    J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease.
    Érsek B; Lupsa N; Pócza P; Tóth A; Horváth A; Molnár V; Bagita B; Bencsik A; Hegyesi H; Matolcsy A; Buzás EI; Pós Z
    Cell Mol Life Sci; 2016 Oct; 73(20):3935-47. PubMed ID: 27137185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of peripheral tolerance through controlled tissue homing of antigen-specific T cells in K14-mOVA mice.
    Bianchi T; Pincus LB; Wurbel MA; Rich BE; Kupper TS; Fuhlbrigge RC; Boes M
    J Immunol; 2009 Apr; 182(8):4665-74. PubMed ID: 19342642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein.
    Liu Z; Chen H; Chen X; Gao J; Guo Z
    PLoS One; 2016; 11(10):e0162905. PubMed ID: 27727269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligands.
    Duckworth BC; Lafouresse F; Wimmer VC; Broomfield BJ; Dalit L; Alexandre YO; Sheikh AA; Qin RZ; Alvarado C; Mielke LA; Pellegrini M; Mueller SN; Boudier T; Rogers KL; Groom JR
    Nat Immunol; 2021 Apr; 22(4):434-448. PubMed ID: 33649580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 T cells induce T-bet-dependent migration toward CXCR3 ligands by differentiated B cells produced during responses to alum-protein vaccines.
    Serre K; Cunningham AF; Coughlan RE; Lino AC; Rot A; Hub E; Moser K; Manz R; Ferraro A; Bird R; Toellner KM; Demengeot J; MacLennan IC; Mohr E
    Blood; 2012 Nov; 120(23):4552-9. PubMed ID: 23065152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system.
    Christensen JE; de Lemos C; Moos T; Christensen JP; Thomsen AR
    J Immunol; 2006 Apr; 176(7):4235-43. PubMed ID: 16547260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00152 mediates CD8
    Ou J; Lei P; Yang Z; Yang M; Luo L; Mo H; Luo G; He J
    J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
    Karin N
    Front Immunol; 2020; 11():976. PubMed ID: 32547545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
    Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
    Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.